SCHEMBL23130141

SCHEMBL23130141

CCC(=O)OCOC(=O)c1cccc2c1OB(O)C(NC(=O)CCCC(C)=O)C2

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23130140 1.00 MAPT (0.30) MAPT
SCHEMBL23130274 0.93 MAPT (0.31) MAPT
SCHEMBL17347699 0.93 MAPT (0.31) MAPT
SCHEMBL23129717 0.91 MAPT (0.30) MAPT
SCHEMBL17337390 0.91 TSHR (0.35) MAPT
SCHEMBL17337392 0.91 TSHR (0.35) MAPT
SCHEMBL17347704 0.90 KMT2A (0.32) MAPT
SCHEMBL17347740 0.90 PRKCB (0.33) —
SCHEMBL23130069 0.90 PRKCB (0.33) —
SCHEMBL23129939 0.90 KMT2A (0.32) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154989-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
Send feedback